Replies to post #79742 on Biotech Values

[DewDiligence]

LOL re latest PR from HEB:

http://finance.yahoo.com/news/Hemispherx-Biopharma-Reports-pz-2221918825.html

As with last year's Annual Meeting of Stockholders, there was an extremely low turnout. The Company believes that this was due to the fact that more than 40% of its outstanding shares are held outside the United States.

Here’s a better explanation, IMO: The kinds of investors who are serious enough to bother to attend an annual meeting already know that your company is a freaking scam.